A sample end user license agreement between an authorized user and a company, covering specific terms and conditions of usage such as license grant, restrictions, user obligations, proprietary rights, feedback and submission, liability limitations, indemnity, and a governing law clause (United States).
A sample terms of service agreement between an individual and a company concerning the use of the company's website. This agreement includes clauses for license grants, restrictions, user obligations, privacy, and postings.
This Latham & Watkins article analyzes the proposed rules and advises SEC registrants on how to prepare for compliance with the proposed cyber rules in May of 2022.
The importance of data security in the digital era cannot be overstated. Businesses must assess data security risks and implement programs accordingly to protect the confidentiality, integrity and availability of collected data.
This is a checklist of steps organizations could take to minimize the chance and impact of a successful ransomware attack, and to be prepared to respond.
This sample agreement is intended for use in business-to-business arrangements. The agreement is drafted on the basis that the Customer will pay the Supplier a fixed fee for development of the website, and that payments will be staged. Resource published in 2015 and republished in 2023.
This is a sample data privacy compliance consent form for employees.
Canada is an attractive market for pharmaceutical manufacturers. Most Canadian consumers have some form of drug coverage through government programs and/or private insurance. Below are ten patent and regulatory topics that in-house counsel need to know before bringing an innovative product to Canada.
Editor's note: This article was updated to reflect recent developments; the original version of this article was published on December 16, 2020.
The September 2017 amendments to the Patented Medicines (Notice of Compliance) Regulations introduced a new scheme for pharmaceutical patent linkage litigation in Canada. That scheme is now much closer to the United States' (US) Hatch-Waxman scheme, but with remaining key differences that are explained in this chart.
Amendments to the Canadian Patent Act and enactment of the Certificate of Supplementary Protection Regulations flowing from the Canada-European Union (EU) Comprehensive Economic and Trade Agreement introduced a new framework in Canada for the issuance of Certificates of Supplementary Protection (CSPs).
This chart compare key aspects of the two regimes, Canada's and the EU's.